Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 72 | 1.260 |
Why?
|
| Coronary Vessel Anomalies | 10 | 2021 | 282 | 1.100 |
Why?
|
| Coronary Vessels | 6 | 2023 | 558 | 0.940 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 730 | 0.900 |
Why?
|
| Myocarditis | 2 | 2022 | 129 | 0.870 |
Why?
|
| Pericarditis | 1 | 2022 | 42 | 0.740 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2021 | 15 | 0.740 |
Why?
|
| Gastrostomy | 1 | 2021 | 86 | 0.700 |
Why?
|
| Hyperglycemia | 1 | 2022 | 225 | 0.700 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 375 | 0.680 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 146 | 0.670 |
Why?
|
| Systemic Inflammatory Response Syndrome | 6 | 2022 | 174 | 0.650 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 47 | 0.630 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 29 | 0.630 |
Why?
|
| Tracheostomy | 1 | 2021 | 197 | 0.620 |
Why?
|
| Hospitalists | 1 | 2019 | 44 | 0.610 |
Why?
|
| Coronary Circulation | 1 | 2019 | 216 | 0.600 |
Why?
|
| Pneumonia | 1 | 2022 | 325 | 0.600 |
Why?
|
| Vaccination | 3 | 2023 | 963 | 0.590 |
Why?
|
| Heart Defects, Congenital | 5 | 2022 | 1825 | 0.550 |
Why?
|
| Child | 35 | 2024 | 24424 | 0.550 |
Why?
|
| Pericardium | 1 | 2017 | 83 | 0.530 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2023 | 144 | 0.520 |
Why?
|
| Ventricular Function, Left | 5 | 2023 | 509 | 0.520 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 101 | 0.520 |
Why?
|
| Teratoma | 1 | 2017 | 120 | 0.510 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2020 | 259 | 0.480 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 1120 | 0.460 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 763 | 0.460 |
Why?
|
| Gestational Age | 2 | 2017 | 1167 | 0.450 |
Why?
|
| Fetal Diseases | 1 | 2017 | 456 | 0.420 |
Why?
|
| Connective Tissue Diseases | 2 | 2023 | 30 | 0.410 |
Why?
|
| Hospitalization | 1 | 2021 | 1783 | 0.410 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2023 | 55 | 0.390 |
Why?
|
| Fetal Heart | 3 | 2017 | 120 | 0.380 |
Why?
|
| Coronary Angiography | 6 | 2021 | 450 | 0.380 |
Why?
|
| Coronary Aneurysm | 2 | 2023 | 33 | 0.360 |
Why?
|
| Infliximab | 2 | 2021 | 65 | 0.340 |
Why?
|
| Humans | 46 | 2024 | 125128 | 0.330 |
Why?
|
| Aorta, Thoracic | 3 | 2021 | 533 | 0.320 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2018 | 257 | 0.320 |
Why?
|
| Child, Preschool | 16 | 2024 | 14027 | 0.310 |
Why?
|
| Myocardial Perfusion Imaging | 4 | 2021 | 56 | 0.290 |
Why?
|
| Male | 30 | 2024 | 61501 | 0.290 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 268 | 0.270 |
Why?
|
| Retrospective Studies | 12 | 2023 | 16348 | 0.270 |
Why?
|
| Infant | 12 | 2024 | 12515 | 0.260 |
Why?
|
| Echocardiography, Doppler | 2 | 2019 | 171 | 0.260 |
Why?
|
| Echocardiography | 5 | 2019 | 1056 | 0.260 |
Why?
|
| Female | 28 | 2024 | 66781 | 0.260 |
Why?
|
| Adolescent | 18 | 2024 | 19361 | 0.250 |
Why?
|
| Glucocorticoids | 3 | 2023 | 383 | 0.250 |
Why?
|
| Stroke Volume | 3 | 2023 | 490 | 0.240 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 3724 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 370 | 0.230 |
Why?
|
| Exercise | 2 | 2021 | 816 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 813 | 0.210 |
Why?
|
| Cardiac Catheterization | 5 | 2020 | 634 | 0.210 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 44 | 0.210 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2018 | 971 | 0.210 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 577 | 0.190 |
Why?
|
| Aftercare | 1 | 2022 | 149 | 0.180 |
Why?
|
| United States | 9 | 2023 | 10891 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 90 | 0.180 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 49 | 0.180 |
Why?
|
| Syncope | 1 | 2021 | 51 | 0.170 |
Why?
|
| Vascular Resistance | 2 | 2018 | 189 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 167 | 0.170 |
Why?
|
| Fever | 2 | 2021 | 299 | 0.170 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 21 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8232 | 0.170 |
Why?
|
| Weight Gain | 1 | 2022 | 400 | 0.160 |
Why?
|
| Time Factors | 5 | 2022 | 6329 | 0.160 |
Why?
|
| Risk Factors | 9 | 2022 | 10314 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2021 | 1178 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1037 | 0.160 |
Why?
|
| Longevity | 1 | 2020 | 135 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5176 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 84 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2022 | 494 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2021 | 156 | 0.150 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 35 | 0.150 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 2173 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2024 | 6150 | 0.150 |
Why?
|
| Pandemics | 2 | 2022 | 1108 | 0.150 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.140 |
Why?
|
| Mitral Valve | 2 | 2016 | 250 | 0.140 |
Why?
|
| Disease Management | 2 | 2021 | 528 | 0.140 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 290 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3423 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 74 | 0.140 |
Why?
|
| Age Factors | 6 | 2020 | 2823 | 0.140 |
Why?
|
| Myocardial Bridging | 1 | 2017 | 12 | 0.140 |
Why?
|
| Aorta | 2 | 2017 | 552 | 0.140 |
Why?
|
| Diseases in Twins | 1 | 2017 | 94 | 0.130 |
Why?
|
| Incidence | 2 | 2022 | 3146 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 345 | 0.130 |
Why?
|
| Survival Rate | 2 | 2019 | 2062 | 0.130 |
Why?
|
| Computed Tomography Angiography | 4 | 2020 | 200 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2022 | 359 | 0.130 |
Why?
|
| Chest Pain | 1 | 2017 | 129 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2020 | 3465 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 110 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 112 | 0.130 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.130 |
Why?
|
| Athletes | 1 | 2016 | 66 | 0.130 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2017 | 175 | 0.130 |
Why?
|
| Drainage | 1 | 2017 | 259 | 0.120 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 41 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 463 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 192 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2022 | 853 | 0.120 |
Why?
|
| Oxygen | 1 | 2018 | 557 | 0.120 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 44 | 0.120 |
Why?
|
| Hyperoxia | 1 | 2016 | 129 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 592 | 0.110 |
Why?
|
| Family | 1 | 2017 | 566 | 0.110 |
Why?
|
| Quality of Life | 2 | 2021 | 1934 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1435 | 0.110 |
Why?
|
| Texas | 2 | 2019 | 3588 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 157 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 213 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 598 | 0.100 |
Why?
|
| Norwood Procedures | 1 | 2014 | 101 | 0.100 |
Why?
|
| Pregnancy | 4 | 2018 | 7208 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 514 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 29611 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2017 | 862 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 772 | 0.080 |
Why?
|
| Cardiology | 1 | 2014 | 507 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 254 | 0.080 |
Why?
|
| Receptors, LDL | 2 | 2019 | 88 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 245 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3073 | 0.060 |
Why?
|
| Young Adult | 3 | 2024 | 9049 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 4811 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 440 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1395 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 55 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2022 | 174 | 0.050 |
Why?
|
| Syncope, Vasovagal | 1 | 2021 | 4 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 283 | 0.050 |
Why?
|
| Prednisolone | 1 | 2021 | 74 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2021 | 17 | 0.040 |
Why?
|
| Platelet Count | 1 | 2021 | 136 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2021 | 93 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 298 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12391 | 0.040 |
Why?
|
| Algorithms | 2 | 2020 | 1629 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 432 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 694 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 78 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 207 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 221 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 641 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 69 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 307 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 68 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 593 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2019 | 257 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 81 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 244 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 275 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 128 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 98 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 264 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1420 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 315 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 56 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 460 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 780 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1287 | 0.030 |
Why?
|
| Critical Care | 1 | 2022 | 657 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2067 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 191 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 978 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 518 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 499 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1606 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 540 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 872 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2016 | 143 | 0.030 |
Why?
|
| Heart Septum | 1 | 2015 | 54 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1897 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 585 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 176 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 112 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1117 | 0.030 |
Why?
|
| Heart Atria | 1 | 2016 | 316 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2014 | 77 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1310 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2016 | 442 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 336 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 278 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 443 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 19870 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4644 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2885 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2458 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 2998 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 5845 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 26920 | 0.010 |
Why?
|